期刊文献+

塞来昔布凝胶的制备与质量控制 被引量:7

The Preparation and Quality Control of Celecoxib Gel
下载PDF
导出
摘要 目的制备塞来昔布凝胶并建立其质量控制方法。方法以卡波姆940为凝胶基质,以月桂氮酮和油酸为透皮吸收促进剂,用二甲亚砜作塞来昔布的溶媒,制备外用凝胶;采用高效液相色谱法测定主药含量。结果该法制得的凝胶均匀细腻,易涂布;建立的色谱方法能排除辅料对塞来昔布的干扰,塞来昔布在2.12~212.00μg.mL-1浓度范围内线性关系良好,平均回收率为100.29%,RSD=0.55%。结论塞来昔布凝胶的制备方法简单,制得的凝胶符合要求,质量控制方法可靠。 Objective To prepare celecoxib gel and to establish the method for its quality control. Methods The celecoxib gel for external use was prepared by using carbopol 940 as the base,laurocapram and oleic acid as skin penetration enhancer and DMSO as solvent for celecoxib and the drug content was determined by HPLC. Results The preparation was stabililty and without irritation.Celecoxib can be completely separated with a linear range of 2.12-212.00 μg·mL-1 and correlation coefficients of r=0.999 9.The average recovery was 100.29% with a RSD of 0.55 %. Conclusion The preparation technique is simple and feasible for the quality control.
出处 《医药导报》 CAS 2010年第7期931-933,共3页 Herald of Medicine
关键词 塞来昔布 凝胶剂 卡波姆 月桂氮酮 油酸 质量控制 Celecoxib Gel Carbopol 940 Laurocapram Oleic acid Quality control
  • 相关文献

参考文献5

二级参考文献10

  • 1张超,郝迎学,刘伟,刘占奎,吕伟.塞来昔布对人结肠癌细胞裸鼠移植瘤肝转移和血管生成的影响[J].第三军医大学学报,2006,28(5):451-453. 被引量:7
  • 2胡岳棣,吴昌平,陶敏,郭晓葵,王彬,茅卫东,吴福林,华东,葛兴国.塞来昔布治疗癌痛的临床研究[J].肿瘤学杂志,2006,12(4):306-308. 被引量:7
  • 3..中国药典二部[S].,2000附录.32..
  • 4Auvinet B,Ziller R,Appelboom T,et al. Compaison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica [J]. Clin Ther, 1995,17: 1078.
  • 5Schonbergr F,Heinkele G,Murdter TE,et al Simple and sensitive method for the determination of celecoxib in serumm by high-performance liquid chromatography with fluorescence detection[J].J Chromatogr B Analyt Technol Biomed Life Sci 2002,Mar 5;768(2)225-260.
  • 6Werner U, Werner D Pahl A et al Investigation of the pharmacokinetics of celecoxib by liquid chromatography--mass spectrometry [J]. Biomed Chromatogr 2002, Feb;16(1): 56 - 60.
  • 7Jayasagar G Kumar MK Chandrasekhar K, et al. Validated HPLC method for the determination of celecoxib in human and its application in a clinical pharmacokinetic study[J]. Pharmazie 2002,Sep;57(9) :619-21.
  • 8Guirguis MS, Sattari S Jamali F Ph armacokinetics of celecoxib in the presence and absence of interinduced acute inflammation in the rat: application of a novel HPLC assay [J]. J Pharm Sci 2001 ,Jan-Apr; 4(1) : 1-6.
  • 9傅得兴,武秀忠.特异性环氧酶-2抑制剂塞来昔布[J].中国新药杂志,2000,9(6):377-379. 被引量:10
  • 10梅之南,施震,汪细和,罗顺德.COX-2抑制剂Celecoxib的合成[J].中国医药工业杂志,2000,31(10):433-434. 被引量:21

共引文献29

同被引文献49

引证文献7

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部